Examination Report |
1 | TM-1 | 16 Jul 2015 |
2 | Additional Representation Sheet | 16 Jul 2015 |
3 | Reply to Exam Report (MIS-R) | 19 Jul 2016 |
4 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 10 Jan 2018 |
5 | Journal Copy | 14 Dec 2018 |
6 | TM-O(NOTICE OF OPPOSITION) | 13 Feb 2019 |
7 | Letters related to TOP | 10 Dec 2019 |
1 | Dispatching of Examination Report for : 3009209 | 3688113 | 1835230 | 27 Jun 2016 |
2 | Hearing Notice (Show Cause) | 6659654 | 3097173 | 13 Jul 2018 |
3 | Tribunal Accepted Notice for : 3009209 | 7089208 | 3270015 | 04 Oct 2018 |
4 | Opposition Notice | 8153633 | 4004873 | 22 Apr 2019 |
5 | Opposition Counter Statement | 8534210 | 4215022 | 04 Jul 2019 |
The application for Bcitam was made on 16 July 2015.
The trademark applicant for Bcitam is Torrent Pharmaceuticals Limited.
Bcitam is applied in class(es) 5.
Application for Bcitam is on Opposed stage.
Application Id allotted to Bcitam is 3009209.
Trademark agent or attorney for the application is Krishna & Saurastri Associates Llp.
Bcitam filed with the Intellectual property office as a DEVICE.